CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0270
+0.000405 (1.52%)
At close: May 18, 2026

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.861.593.251.520.481.1
Cash & Short-Term Investments
0.861.593.251.520.481.1
Cash Growth
-83.52%-51.19%113.76%219.73%-56.68%-
Prepaid Expenses
0.721.070.270.370.230.26
Restricted Cash
-0.070.070.0841.67-
Other Current Assets
--0.11---
Total Current Assets
1.572.733.711.9742.371.36
Property, Plant & Equipment
0.630.911.993.16--
Long-Term Deferred Tax Assets
-----0.02
Long-Term Deferred Charges
--0.5---
Other Long-Term Assets
-----178.7
Total Assets
2.213.646.215.1342.37180.08
Accounts Payable
7.697.584.511.671.650.01
Accrued Expenses
0.70.71.910.1400.08
Short-Term Debt
---0.60.65-
Current Portion of Leases
0.460.70.880.77--
Current Income Taxes Payable
----0.6-
Other Current Liabilities
2.480.110.110.3227.84-
Total Current Liabilities
11.339.097.43.5130.750.1
Long-Term Leases
--0.71.58--
Other Long-Term Liabilities
----22.62187.65
Total Liabilities
11.469.098.15.0853.37187.75
Common Stock
000000
Additional Paid-In Capital
80.2978.1367.141.03--
Retained Earnings
-96.72-90.84-70.92-43.09-11-7.67
Comprehensive Income & Other
-0.04--1.3---
Total Common Equity
-16.48-12.71-5.07-42.06-11-7.67
Shareholders' Equity
-9.26-5.45-1.890.04-11-7.67
Total Liabilities & Equity
2.213.646.215.1342.37180.08
Total Debt
0.60.71.582.940.65-
Net Cash (Debt)
0.260.891.68-1.42-0.171.1
Net Cash Growth
-93.25%-47.01%----
Net Cash Per Share
0.020.2165.72--15.48-
Filing Date Shares Outstanding
45.1136.790.27--0.01
Total Common Shares Outstanding
36.0121.10.12--0.01
Working Capital
-9.75-6.35-3.69-1.5411.621.26
Book Value Per Share
-0.46-0.60-41.98---667.47
Tangible Book Value
-16.48-12.71-5.07-42.06-11-7.67
Tangible Book Value Per Share
-0.46-0.60-41.98---667.47
Machinery
-2.552.552.55--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.